Bryan & Sang Medical Assoc Aiken, SC - 29801

Bryan & Sang Medical Assoc is categorized under Gynecologists and OB GYNs in Aiken, SC and active since 1975.

Bryan & Sang Medical Assoc was established in 1975, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Gynecologists and OB GYNs business, which does work in the B2C market, and is classified as a Gynecologists and OB GYNs, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Evadna Sangbryan, Owner at the company’s single location by writing to 209 Abbeville Avenue Nw, Aiken, South Carolina SC 29801 or by phoning (803) 648-0874. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Bryan & Sang Medical Assoc
Contact Person: Evadna Sangbryan, Owner
Address: 209 Abbeville Avenue Nw, Aiken, South Carolina 29801
Phone Number: (803) 648-0874
Annual Revenue (USD): $500.000 to $999.999
Founded: 1975
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Gynecologists and OB GYNs
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Bryan & Sang Medical Assoc was started in 1975 to provide professional Gynecologists and OB GYNs under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Evadna Sangbryan, Owner for inquiries that concern Bryan & Sang Medical Assoc by calling the company number (803) 648-0874, as your correspondence is most welcome. Additionally, the physical location of the single location of Bryan & Sang Medical Assoc can be found at the coordinates 33.56678,-81.71846 as well as the street address 209 Abbeville Avenue Nw in Aiken, South Carolina 29801.

For its online presence, you may visit Bryan & Sang Medical Assoc’s website at and engage with its social media outlets through on Twitter and on Facebook.